Thursday, December 10, 2015 9:47:24 AM
I agree, Woodford has no reason to drive the price down and undermine the other $150 million invested just to get a cheaper entry point on the last $30 million. He has every incentive to see it higher, as this has currently put him and his fund in a poor light, with lots of negative press. He was buying hand over fist in the open market in July and August, right up to $12 price.
No, I don't think he is stupid, and I do still believe he is in possession of information on the hold that none of us are. That is why I believe he is not supporting the current price as he was in July and August. I am convinced he signed a non-disclosure at the end of August or early September.
The enrollment hold has everyone else sitting on their hands (baring a few die-hard longs with dry powder), so we just wallow in the muck and fear until some news it announced around this subject, or some other positive development. It seems nobody is willing to sell until that happens. Also, there are 13 million shorts that need to cover, unless the company goes completely belly up.
No, I don't think he is stupid, and I do still believe he is in possession of information on the hold that none of us are. That is why I believe he is not supporting the current price as he was in July and August. I am convinced he signed a non-disclosure at the end of August or early September.
The enrollment hold has everyone else sitting on their hands (baring a few die-hard longs with dry powder), so we just wallow in the muck and fear until some news it announced around this subject, or some other positive development. It seems nobody is willing to sell until that happens. Also, there are 13 million shorts that need to cover, unless the company goes completely belly up.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
